NYT -- The French pharmaceutical giant Sanofi-Aventis said on Wednesday that it was issuing $7 billion worth of notes to help finance its acquisition of the American biotechnology firm Genzyme, which it agreed to last month.
NYT -- The French pharmaceutical giant Sanofi-Aventis said on Wednesday that it was issuing $7 billion worth of notes to help finance its acquisition of the American biotechnology firm Genzyme, which it agreed to last month.
